Mehmet ÖZSÜRMELİ, Ercan BAŞTU, Cihan COMBA, Mete SUCU, Erol ARSLAN, Selahattin MISIRLIOĞLU, Faruk ÇELİK, Şakir Ümit ZEYBEK, Ahmet BÜYÜKÖREN

Oral kontraseptif kullanan kadınlarda inflamatuvar belirteçlerinin ve adezyon moleküllerinin değişimi

Amaç: Bu çalışmanın amacı, oral kontraseptiflerin adezyon moleküllerinin serum seviyelerine olan etkisini araştırarak, sentetik östrojenlerin ateroskleroza karşı koruyucu etkisi olup olmadığı saptamaktır.Gereç ve Yöntem: Ek hastalığı bulunmayan, kontrasepsiyon amaçlı en az 3 aydır oral kontraseptif kullanan, 18-45 yaş aralığında olan hastaların serum interlökin 6 (İL-6), tümör nekrozis faktör alfa (TNF alfa), damarsal hücre yapışma molekülü 1 (VCAM-1), hücreler arası adezyon molekülü (ICAM-1), E selektin, P selektin, c reaktif protein (CRP) seviyeleri ve eritrosit sedimentasyon hızları (ESH); ek hastalığı bulunmayan, düzenli adet gören, 18-45 yaş aralığında olan sağlıklı gönüllülerle karşılaştırıldı.Bulgular: Her iki grubun VCAM-1, ICAM-1, E selektin, P selektin, TNF alfa, İL 6, ESH seviyeleri arasında anlamlı fark saptanmadı. Oral kontraseptif kullanan grupta serum CRP seviyeleri anlamlı olarak daha yüksek saptandı.Sonuç: Oral kontraseptiflerin adezyon moleküllerinin serum seviyelerini değiştirdiği gösterilemiştir. Serum crp seviyelerinin değişimleri ise karaciğer ilk geçiş etkisine bağlanmaktadır.

Anahtar Kelimeler:

Oral kontraseptifler, hücrelerarası yapışma molekülü-1

Alteration of inflammatory markers and adhesion molecules in women using oral contraceptives

Purpose: The aim of the study is examine the effect of oral contraceptives on the serum levels of adhesion molecules and identify if the synthetic oestrogens provide protection against atherosclerosis.Materials and Methods: The interleukin 6 (IL-6), Tumor necrosis factor alfa (TNF Alfa), Vascular cell adhesion molecule 1 (VCAM-1), Intercellular Adhesion Molecule (ICAM-1), E selectin, P selectin, C selectin, C Reactive Protein (CRP) levels and erythrocyte sedimentation rate (ESH) of patients between 18-45, without additional illness, using oral contraceptives for contraception at least for three years were compared to healthy volunteers, aged between 18-45, having regular menstruation and without any additional diseases.Results: There has been no meaningful difference between the VCAM-1, ICAM-1, E selectin, P selectin, TNF alfa, IL 6, ESH levels of the two groups. Serum CRP levels are meaningfully higher in the group using oral contraceptives.Conclusion: Oral contraceptives change the serum levels of adhesion molecules. The change in the serum CRP levels might be due to the liver first pass effect.

Keywords:

Oral contraceptives Intercellular Adhesion Molecule-1, Mediators of Inflammation,

PDF

___

1. Nofer JR. Estrogens and atherosclerosis:insights from animal models and cell systems. J Mol Endocrinol. 2012;48:13-29.
2. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program- Adult treatment Panel 3, İnternational Diabetes Federation, and Worl Health Organization Definitions of the metabolic syndrome as predictors of incident cardiovascular diseas and diabetes. Diabetes care. 2007;30:8-13.
3. Kaseta Jr, Skafar DF, Ram JL, Jacober SJ, Sowers JR. Cardiovascular diseas in the diabetic woman. J Clin Endocrinol Metab. 1999;84:1835-38.
4. Clarkson TB. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Menopause. 2007;14:373- 84.
5. Libby P. The moleculer bases of acute coronary syndromes. Circulation. 1995;91:2844-50.
6. Libby P. Vascular biology of atherosclerosis: overview and state of the art. Am J Cardiol. 2003;91:3–6.
7. Souter I, Janzen C, Martinez Maza O, Breen EC, Stanczyk F, Chaudhuri G et al. Serum levels of soluble vascular cell adhesion molecule-1 are decreased in women receiving oral contraceptives comparede with normally menstruating women:Implications in atherosclerosis. Fertil Steril. 2005;83:1480-8.
8. Nathan L, Pervin S, Singh R, Rosenfeld M, Chaudhuri G. Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo: possible mechanisms for gender differences in atherosclerosis. Circulation Research. 1999;85:377–85.
9. Cushman M, Legault C, Barrett-Connor E, Stefanick ML, Kessler C, Judd HL et al. Effect of postmenopausal hormones on inflammationsensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation. 1999;100:717–22.
10. Jilma B, Hildebrandt J, Kapiotis S, Wagner OF, Kitzweger E, Mullner C et al. Effects of estradiol on circulating P-selectin. J Clin Endo Metab. 1996;81:2350–5.
11. Grandi G, Napolitano A, Cagnacci A. Metabolic impact of combined hormonal contraceptives containing estradiol. Exp Opin Drug Metab Toxicol. 2016;12:779–87.
12. Souter I, Huang A, Martinez-Maza O, Breen EC, Decherney AH, Chaudhuri G et al. Serum levels of soluble vascular cell adhesion molecule-1, tumor necrosis factor-a, and interleukin-6 in in vitro fertilization cycles. Fertil Steril. 2009;91:2012–9.
13. Stocco B, Fumagalli HF, Franceschini SA, Martinez EZ, Marzocchi-Machado CM, Toloi MR. Drospirenone and levonorgestrel in combination with either 30 or 20 mcg ethinylestradiol reduce soluble adhesion molecules in Brazilian women; crosssectional study. Contraception. 2012;86:506-10.
14. Tatsumi H, Kitawaki J, Tanaka K, Hosoda T, Honjo H. Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins. Maturitas. 2002;42:287-94.
15. Otsuki M, Saito H, Xu X, Sumitani S, Kouhara H, Kishimoto T et al. Progesterone, but not medroxyprogesterone, inhibits vascular cell adhesion molecule-1 expression in human vascular endothelial cells. Arterioscler Thromb Vasc Biol. 2001;21:243-8.
16. Cagnacci A. Hormonal contraception: venous and arterial disease. Eur J Contracept Reprod Health Care. 2017;22:191-9.
17. Dinger J, Möhner S, Heinemann K. Cardiovascular risks associated with the use of drospirenonecontaining combined oral contraceptives. Contraception. 2016;93:378-85.
18. Raman K, Chong M, Akhtar-Danesh GG, D'Mello M, Hasso R, Ross S et al. Genetic markers of inflammation and their role in cardiovascular disease.Can J Cardiol. 2013;29:67-74.
19. van Rooijen M, Hansson LO, Frostegård J, Silveira A, Hamsten A, Bremme K. Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response. J Thromb Haemost. 2006;4:77-82.
20. Shifren JL, Rifai N, Desindes S, McIlwain M, Doros G, Mazer NA. A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on c-reactive protein, other serum markers of ınflammation, and other hepatic proteins in naturally menopausal women. J Clin Endocrinol Metab. 2008;93:1702-10.